Streetbeat News

Products Services

EVO

Evotec and Variant Bio have entered into a collaboration agreement to discover treatments for diseases caused by fibrosis. Evotec will receive research funding, with potential for pre-clinical and clinical milestones and/or royalties based on the program's success.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:29 am

ECX

ECARX has formed a strategic partnership with FAW Group to develop intelligent cockpits for FAW's premium Hongqi brand vehicles. This collaboration aims to enhance the driving experience by integrating advanced technologies into the vehicle's cockpit, marking a significant step in the automotive industry's shift towards more intelligent and connected vehicles.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:20 am

BLCO

Bausch + Lomb announced that its ONE by ONE and Biotrue Eye Care Recycling Programs have successfully collected 84.3 million units, or 510,116 pounds, of used contact lenses, eye care, and lens care materials in the U.S., highlighting the company's commitment to sustainability and environmental responsibility.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:14 am

SNN

Smith+Nephew announced new evidence supporting the effectiveness of its ALLEVYN LIFE Foam Dressing in preventing pressure injuries. The study highlights the unique layer-on-layer sliding phenomenon of the dressing, which dissipates mechanical energy and reduces the risk of pressure injuries compared to traditional bonded dressings.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:12 am

BNTC

Benitec Biopharma announced a $40 million PIPE financing from the sale of shares and pre-funded warrants to fund clinical development of BB-301 and for general corporate purposes. The financing was oversubscribed, indicating strong investor interest.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:12 am

CMMB

Chemomab announced a new peer-reviewed publication that supports the clinical association of its CCL24 target with disease severity and mortality in Systemic Sclerosis (SSc). A longitudinal study of over 200 real-world patients further validates CCL24 as a novel target for SSc, indicating its association with disease severity across fibrotic and vascular manifestations of the condition.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:11 am

CYN

Cyngn announced a business update, emphasizing its focus on opening new distribution and sales channels to expand its market reach. This strategic move is aimed at enhancing the company's growth prospects by broadening its customer base and improving product accessibility.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:08 am

BTCY

Biotricity Inc. has initiated a pilot program for cardiac monitoring across a hospital system that includes 9 hospitals and 10 clinics. This expansion into a significant healthcare network marks a pivotal step for Biotricity in demonstrating the effectiveness and scalability of their cardiac monitoring solutions.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:08 am

TLSA

Tiziana Life Sciences announced new quantitative PET imaging data on Foralumab at the American Academy of Neurology meeting. This development could indicate progress in their research and potential for future clinical applications.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:06 am

TM

The 2025 Toyota Camrys are set to arrive at Toyota dealerships in late Spring 2024, featuring a starting MSRP of $28,400.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 11:05 am